S-3304 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

January 31, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

S-3304

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00033566 - S-3304 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter